Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Arnicolide D Inhibits Triple Negative Breast Cancer Cell Proliferation by Suppression of Akt/mTOR and STAT3 Signaling Pathways
Zhao Qu, Yu-Shan Lin, Daniel Kam-Wah Mok, et al.
International Journal of Medical Sciences (2020) Vol. 17, Iss. 11, pp. 1482-1490
Open Access | Times Cited: 18

Showing 18 citing articles:

Arnicolide D induces endoplasmic reticulum stress-mediated oncosis via ATF4 and CHOP in hepatocellular carcinoma cells
Yu-Shan Lin, Zhiwei Sun, Lisha Shen, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy
Abdelhakim Bouyahya, Aicha El Allam, Sara Aboulaghras, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5520-5520
Open Access | Times Cited: 37
Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer
Long Lin, Xiangyu Fei, Liucui Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Current advances in the pain treatment and mechanisms of Traditional Chinese Medicine
Xiaoli Zhu, Zhuolin Jia, Ye Zhou, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 4114-4139
Closed Access | Times Cited: 4
Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways
Chi Teng, Jiawen Chen, Lisha Shen, et al.
Cancer Drug Resistance (2025)
Open Access
Promising anticancer activities and mechanisms of action of active compounds from the medicinal herb Centipeda minima (L.) A. Braun & Asch
Yongqiang Liu, Guang‐Biao Zhou
Phytomedicine (2022) Vol. 106, pp. 154397-154397
Closed Access | Times Cited: 16
Arnicolide D: a multi-targeted anticancer sesquiterpene lactone—preclinical efficacy and mechanistic insights
Shivaprasad Shetty Mangalpady, Sheila I. Peña‐Corona, Fabiola V. Borbolla-Jiménez, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6317-6336
Closed Access | Times Cited: 3
Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer
Rajibul Islam, Khor Poh Yen, Nur Najihah Izzati Mat Rani, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117877-117877
Open Access | Times Cited: 3
Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology
Jingjing Yao, Qinghong Shen, Min Huang, et al.
Journal of Ethnopharmacology (2021) Vol. 282, pp. 114583-114583
Closed Access | Times Cited: 13
Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
Ji Yun Baek, Byoung Ha Kim, Dong‐Wook Kim, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 5071-5083
Open Access | Times Cited: 4
Exploration of altered miRNA expression and function in MSC-derived extracellular vesicles in response to hydatid antigen stimulation
Xin Wang, Wubulikasimu Mijiti, Qiyu Jia, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Arnicolide D Inhibits Oxidative Stress-induced Breast Cancer Cell Growth and Invasion through Apoptosis, Ferroptosis, and Parthanatos
Wei Wen, Ke Jin, Ying Che, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 24, Iss. 11, pp. 836-844
Closed Access | Times Cited: 6
The efficacy of natural products for the treatment of nasopharyngeal carcinoma
Xudong Ao, Chao Luo, Mengni Zhang, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 2
Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics
Amiya Das, Pallavi Agarwal, Gaurav Jain, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 3, pp. 515-550
Closed Access | Times Cited: 5
Exploring the in vitro and in vivo anticancer activity of lasiokaurin on nasopharyngeal carcinoma
Huanhuan Pu, Lin Jin-rong, Lisha Shen, et al.
Pharmacological Research - Modern Chinese Medicine (2023) Vol. 9, pp. 100303-100303
Open Access | Times Cited: 1
Arnicolide D Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells through PI3K/Akt/mTOR Pathway
Zhuo Chen, Renhua Ni, Yuanyu Hu, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 17, pp. 1288-1294
Closed Access
In Vitro and In Vivo Anti-Cancer Activity of Lasiokaurin in a Triple-Negative Breast Cancer Model
Lin Jin-rong, Zhao Qu, Huanhuan Pu, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7701-7701
Open Access
Phytochemical Small Molecules as Potential Anti-angiogenesis Targeted Therapy for Triple-Negative Breast Cancer
Khor Poh Yen
Revista Brasileira de Farmacognosia (2023) Vol. 34, Iss. 3, pp. 451-466
Closed Access
Page 1

Scroll to top